On November 7-8, the 2024 annual conference of the Rongxiang Xu Center for Regenerative Therapeutics at Beth Israel Deaconess Medical Center (BIDMC) was held in Boston, US. The conference focused on innovative treatments for diabetic lower extremity disease, attracting global experts to share academic progress.

Dr. Marc Schermerhorn, Chief of Vascular Surgery at Harvard’s BIDMC, updated on lower extremity disease combined with ischemia, future development trends, and the latest academic research results from the center.

Dr. Mar Florentino from the Philippines and Dr. Edwin Widjaja from Indonesia, shared their experience in successfully applying regenerative medical technology in treating diabetic foot ulcers. They emphasized the unique benefits of this technique in improving healing outcomes.

Gala dinner was held at the Harvard Club, hosted by Dr. Aristidis Veves, Director of the center. Li Li, Chairperson of the National Rongxiang Xu Foundation, was invited to this event. Dr. Veves sincerely expressed his gratitude to the National Rongxiang Xu Foundation. Besides, he also mentioned that research progress in treating diabetic lower extremity disease has been made under the cooperation between the center and the foundation. Moreover, he looked forward to continuously deepening cooperation between the two parties to continue to build academic exchange platforms around the world. After his speech, Li Li highly recognized the efforts and achievements made by the center in recent years. She also expressed her expectation that the center can further expand the scope of research and increase the depth of research in the future. She hoped the deepening cooperation between the two parties could promote development in treating diabetic lower extremity diseases and benefit more and more patients in the future.